Among ALL-diagnosed patients, CXCR7 expression was more pronounced in the T-ALL subtype (T-ALL; 742.2 [629.9 to 793.3] versus (vs.)B-ALL; 637.9 [600.1 to 809.8]; median [minimum – maximum]) (Figure 2B). The gene discussed is ACKR3; the disease is acute lymphoblastic leukemia.